Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year Results, Presents Financial Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall St set to open lower after AI-led selloff; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- JetBlue shares fall amid American results, fuel cost concerns
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Nokia shares fall despite earnings beat on cash flow concerns
Phibro Animal Health (PAHC) Misses Q4 EPS by 3c, Revenues Misss; Provides FY20 EPS Guidance Below Consensus
August 27, 2019 4:18 PM EDTPhibro Animal Health (NASDAQ: PAHC) reported Q4 EPS of $0.33, $0.03 worse than the analyst estimate of $0.36. Revenue for the quarter came in at $204 million versus the consensus estimate of $206 million.
Highlights for the June 2019 quarter (compared to the June 2018 quarter)
Net sales of $204 million, a decrease of $8 million, or 4%Net income of $9 million, a decrease of $13 million, or 60%Diluted EPS of $0.22, a decrease of $0.33, or 60%Adjusted EBITDA of $26 million, a decrease of $7 million, or 20%Adjusted diluted EPS of $0.33, a decrease of $0.13, or... More


